GlassScriptPhysician profile
Nirjaleshwar Nikhar
NPI 1366537938
$2,206.35
in general payments reported to CMS, 2019-2025
21 companies · $65.81 in 2025
The $65.81 reported for 2025 was less than what a typical Neurology (Psychiatry & Neurology) provider received nationally (typical 2025 total: $454).
See the full distribution for Neurology (Psychiatry & Neurology)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $791 · 2020: $306 · 2021: $261 · 2022: $388 · 2023: $263 · 2024: $131 · 2025: $65.81.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $460.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $460.49 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Teva Pharmaceuticals USA, INC. | $725.22 | 2019-2024 | Ajovy |
| Alexion Pharmaceuticals, INC. | $325.88 | 2019-2021 | |
| Novartis Pharmaceuticals Corporation | $313.57 | 2019-2025 | |
| Lilly USA, LLC | $135.22 | 2019-2021 | |
| Abbvie INC. | $120.06 | 2021-2023 | |
| Insightec,INC | $110.46 | 2023 | Exablate |
| Horizon Therapeutics Plc | $70.09 | 2021-2022 | |
| Jazz Pharmaceuticals INC. | $67.47 | 2020-2023 | |
| Lundbeck LLC | $66.18 | 2020-2023 | Vyepti |
| Sunovion Pharmaceuticals INC. | $49.52 | 2020-2021 | |
| Emd Serono, INC. | $29.98 | 2025 | |
| Harmony Biosciences LLC | $27.24 | 2022 | |
| Allergan, INC. | $24.49 | 2020 | |
| Tanabe Pharma America, INC. | $23.50 | 2020 | |
| Ucb, INC. | $20.88 | 2025 | Rystiggo |
Show all 21 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Argenx US, INC. | $20.69 | 2023 | Vyvgart Hytrulo |
| Eisai INC. | $17.86 | 2024 | |
| Amgen INC. | $17.26 | 2020 | |
| Adamas Pharmaceuticals, INC. | $13.84 | 2020 | |
| Biohaven Pharmaceuticals, INC. | $13.58 | 2021 | |
| E.R. Squibb & Sons, L.L.C. | $13.36 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Nirjaleshwar Nikhar listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.